Sanofi’s vaccines business leaned on strong performances from pediatric, flu and travel shots on the way to 13.2% growth in Q1.
WHO plans real-world pilot studies of GlaxoSmithKline’s malaria jab Mosquirix in three African countries.
Vaccination rates among kindergarteners reached a record high in California after a tougher vaccine law went into effect.
Themis is the most recent company to usher a Zika vaccine to the clinic.
Sanofi Pasteur's dengue vaccine Dengvaxia will have to undergo phase 4 testing in Malaysia.
GlaxoSmithKline’s U.S. vaccine R&D head Ripley Ballou says emerging disease vaccine research needs a shakeup—and here's how.
Argentina's Sinergium Biotech, which is in a consortium to develop a Zika virus vaccine, intends to build a new plant that will use cell biology that can…
Takeda has finished enrolling 20,100 children for a massive phase 3 dengue vaccine study.
After successfully shepherding a Zika vaccine candidate into the clinic before any other developer, Inovio Pharmaceuticals is amping up its efforts in HIV.
The NIH's Zika vaccine will move into phase 2 testing, officials said Friday. Despite the president's threats of spending cuts, this project is fully…